Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
Read Me

Impel Neuropharma Announces Key Management Team Appointments as Company Advances Toward Commercialization in 2021
Read Me

Homology Medicines Regains Worldwide Rights to Ophthalmology Program Based on its In Vivo Nuclease-Free Gene Editing Platform
Read Me

Pear Therapeutics Announces Second Closing of Series D Financing
Read Me

Artiva Raises $120M in Series B Financing to Advance Pipeline of Allogeneic NK Cell Therapies

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA

San Francisco

501 Second Street
Suite 350
San Francisco, CA 94107

Tel: 415-993-8570
Boston

200 Clarendon Street
45th Floor
Boston, MA 02116

Tel: 857-305-1825

© 2021 5AM Venture Management LLC